{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["antibacterial phytochemicals", "antibiotic resistance", "bacterial protein targets", "molecular docking"]], "OtherID": [], "CitationSubset": [], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27626453", "DateCompleted": {"Year": "2016", "Month": "09", "Day": "15"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "09", "Day": "12"}], "ELocationID": ["30", "10.3390/antibiotics5030030"], "Language": ["eng"], "Journal": {"ISSN": "2079-6382", "JournalIssue": {"Volume": "5", "Issue": "3", "PubDate": {"Year": "2016", "Month": "Sep", "Day": "12"}}, "Title": "Antibiotics (Basel, Switzerland)", "ISOAbbreviation": "Antibiotics (Basel)"}, "ArticleTitle": "The Search for Herbal Antibiotics: An In-Silico Investigation of Antibacterial Phytochemicals.", "Abstract": {"AbstractText": ["Recently, the emergence and spread of pathogenic bacterial resistance to many antibiotics (multidrug-resistant strains) have been increasing throughout the world. This phenomenon is of great concern and there is a need to find alternative chemotherapeutic agents to combat these antibiotic-resistant microorganisms. Higher plants may serve as a resource for new antimicrobials to replace or augment current therapeutic options. In this work, we have carried out a molecular docking study of a total of 561 antibacterial phytochemicals listed in the Dictionary of Natural Products, including 77 alkaloids (17 indole alkaloids, 27 isoquinoline alkaloids, 4 steroidal alkaloids, and 28 miscellaneous alkaloids), 99 terpenoids (5 monoterpenoids, 31 sesquiterpenoids, 52 diterpenoids, and 11 triterpenoids), 309 polyphenolics (87 flavonoids, 25 chalcones, 41 isoflavonoids, 5 neoflavonoids, 12 pterocarpans, 10 chromones, 7 condensed tannins, 11 coumarins, 30 stilbenoids, 2 lignans, 5 phenylpropanoids, 13 xanthones, 5 hydrolyzable tannins, and 56 miscellaneous phenolics), 30 quinones, and 46 miscellaneous phytochemicals, with six bacterial protein targets (peptide deformylase, DNA gyrase/topoisomerase IV, UDP-galactose mutase, protein tyrosine phosphatase, cytochrome P450 CYP121, and NAD\u207a-dependent DNA ligase). In addition, 35 known inhibitors were docked with their respective targets for comparison purposes. Prenylated polyphenolics showed the best docking profiles, while terpenoids had the poorest. The most susceptible protein targets were peptide deformylases and NAD\u207a-dependent DNA ligases."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA. mary.setzer@uah.edu."}], "LastName": "Snow Setzer", "ForeName": "Mary", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zabol Medicinal Plants Research Center, Zabol University of Medical Sciences, Zabol 61615-585, Iran. javad.sharifirad@gmail.com."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy, Zabol University of Medical Sciences, Zabol 61615-585, Iran. javad.sharifirad@gmail.com."}], "LastName": "Sharifi-Rad", "ForeName": "Javad", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA. wsetzer@chemistry.uah.edu."}], "LastName": "Setzer", "ForeName": "William N", "Initials": "WN"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Antibiotics (Basel)", "NlmUniqueID": "101637404", "ISSNLinking": "2079-6382"}, "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Centers for Disease Control and Prevention (CDC) Antibiotic Resistance Threats in the United States. CDC; Atlanta, GA, USA: 2013."}, {"Citation": "Alam O., Deng T. Environmental and public health risks associated with antibiotic resistance genes (ARGs) spread in environment: A comprehensive review. Int. J. Sci. Res. Sci. Technol. 2015;1:128\u2013139."}, {"Citation": "Blair J.M., Webber M.A., Baylay A.J., Ogbolu D.O., Piddock L.J. Molecular mechanisms of antibiotic resistance. Nat. Rev. Microbiol. 2015;31:42\u201351. doi: 10.1038/nrmicro3380.", "ArticleIdList": ["10.1038/nrmicro3380", "25435309"]}, {"Citation": "Economou V., Gousia P. Agriculture and food animals as a source of antimicrobial-resistant bacteria. Infect. Drug Resist. 2015;8:49\u201361. doi: 10.2147/IDR.S55778.", "ArticleIdList": ["10.2147/IDR.S55778", "PMC4388096", "25878509"]}, {"Citation": "Chang H.H., Cohen T., Grad Y.H., Hanage W.P., O\u2019Brien T.F., Lipsitch M. Origin and proliferation of multiple-drug resistance in bacterial pathogens. Microbiol. Mol. Biol. Rev. 2015;79:101\u2013116. doi: 10.1128/MMBR.00039-14.", "ArticleIdList": ["10.1128/MMBR.00039-14", "PMC4402963", "25652543"]}, {"Citation": "Van Hal S.J., Fowler V.G. Is it time to replace vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections? Clin. Pract. 2013;56:1779\u20131788. doi: 10.1093/cid/cit178.", "ArticleIdList": ["10.1093/cid/cit178", "PMC3658366", "23511300"]}, {"Citation": "Nathwani D., Raman G., Sulham K., Gavagham M., Menon V. Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: A systematic review and meta-analysis. Antimicrob. Resist. Infect. Control. 2014 doi: 10.1186/2047-2994-3-32.", "ArticleIdList": ["10.1186/2047-2994-3-32", "PMC4219028", "25371812"]}, {"Citation": "Kim L., McGee L., Tomczyk S., Beall B. Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre- and post-conjugate vaccine eras: A United States perspective. Clin. Microbiol. Rev. 2016;29:525\u2013552. doi: 10.1128/CMR.00058-15.", "ArticleIdList": ["10.1128/CMR.00058-15", "PMC4861989", "27076637"]}, {"Citation": "Kempker R.R., Kipiani M., Mirtskhulava V., Tukvadze N., Magoo M.J., Blumberg H.M. Acquired drug resistance in Mycobacterium tuberculosis and poor outcomes among patients with multidrug-resistant tuberculosis. Emerg. Infect. Dis. 2015;21:992\u20131001. doi: 10.3201/eid2106.141873.", "ArticleIdList": ["10.3201/eid2106.141873", "PMC4451915", "25993036"]}, {"Citation": "Kesavan B., Srividhya K.V., Krishnaswamy S., Raja M., Vidya N., Krishna Mohan A.V. Understanding the virulence of the entero-aggregative E. coli O104:H4. Int. J. Bioinf. Res. Appl. 2015;11:187\u2013199. doi: 10.1504/IJBRA.2015.069185.", "ArticleIdList": ["10.1504/IJBRA.2015.069185", "26561016"]}, {"Citation": "Kr\u00fcger A., Lucchesi P.M., Sanso A.M., Etcheverr\u00eda A.I., Bustamante A.V., Burg\u00e1n J., Fern\u00e1ndez D., Leotta G., Friedrich A.W., Padola N.L., et al. Genetic characterization of Shiga toxin-producing Escherichia coli O26:H11 strains isolated from animal, food, and clinical samples. Front. Cell. Infect. Microbiol. 2015 doi: 10.3389/fcimb.2015.00074.", "ArticleIdList": ["10.3389/fcimb.2015.00074", "PMC4612136", "26539413"]}, {"Citation": "Gallois C., Hauw-Berlemont C., Richaud C., Bonacorsi S., Diehl J.L., Mainardi J.L. Fatal necrotizing fasciitis due to necrotic toxin-producing Escherichia coli strain. New Microbes New Infect. 2015;8:109\u2013112. doi: 10.1016/j.nmni.2015.06.003.", "ArticleIdList": ["10.1016/j.nmni.2015.06.003", "PMC4652023", "26693024"]}, {"Citation": "McPhillie M.J., Cain R.M., Marramore S., Fishwick C.W., Simmons K.J. Computational methods to identify new antibacterial targets. Chem. Biol. Drug Des. 2015;85:22\u201329. doi: 10.1111/cbdd.12385.", "ArticleIdList": ["10.1111/cbdd.12385", "24974974"]}, {"Citation": "Bernal F.A., Coy-Barrera E. Molecular docking and multivariate analysis of xanthones as antimicrobial and antiviral agents. Molecules. 2015;20:13165\u201313204. doi: 10.3390/molecules200713165.", "ArticleIdList": ["10.3390/molecules200713165", "PMC6332503", "26197308"]}, {"Citation": "Rahimi H., Najafi A., Eslami H., Negahdari B., Moghaddam M.M. Identification of novel bacterial DNA gyrase inhibitors: An in silico study. Res. Pharm. Sci. 2016;11:250\u2013258.", "ArticleIdList": ["PMC4962306", "27499795"]}, {"Citation": "Ferguson P.P., Holloway W.B., Setzer W.N., McFeeters H., McFeeters R.L. Small molecule docking supports broad and narrow spectrum potential for the inhibition of the novel antibiotic target bacterial Pth1. Antibiotics. 2016 doi: 10.3390/antibiotics5020016.", "ArticleIdList": ["10.3390/antibiotics5020016", "PMC4929431", "27171117"]}, {"Citation": "Saleem M., Nazir M., Ali M.S., Hussain H., Lee Y.S., Riaz N., Jabbar A. Antimicrobial natural products: An update on future antibiotic drug candidates. Nat. Prod. Rep. 2010;27:238\u2013254. doi: 10.1039/B916096E.", "ArticleIdList": ["10.1039/B916096E", "20111803"]}, {"Citation": "Savoia D. Plant-derived antimicrobial compounds: Alternatives to antibiotics. Future Microbiol. 2012;7:979\u2013990. doi: 10.2217/fmb.12.68.", "ArticleIdList": ["10.2217/fmb.12.68", "22913356"]}, {"Citation": "Dictionary of Natural Products on DVD v.23:1. CRC Press; Boca Raton, FL, USA: 2014."}, {"Citation": "Adams J.M., Capecchi M.R. N-formylmethionyl-sRNA as the initiator of protein synthesis. Proc. Natl. Acad. Sci. USA. 1966;55:147\u2013155. doi: 10.1073/pnas.55.1.147.", "ArticleIdList": ["10.1073/pnas.55.1.147", "PMC285768", "5328638"]}, {"Citation": "Lucchini G., Bianchetti R. Initiation of protein synthesis in isolated mitochondria and chloroplasts. Biochim. Biophys. Acta. 1980;608:54\u201361. doi: 10.1016/0005-2787(80)90133-1.", "ArticleIdList": ["10.1016/0005-2787(80)90133-1", "6992873"]}, {"Citation": "Meinnel T., Mechulam Y., Blanquet S. Methionine as translation start signal: A review of the enzymes of the pathway in Escherichia coli. Biochimie. 1993;75:1061\u20131075. doi: 10.1016/0300-9084(93)90005-D.", "ArticleIdList": ["10.1016/0300-9084(93)90005-D", "8199241"]}, {"Citation": "Apfel C.M., Evers S., Hubschwerlen C., Pirson W., Page M.G., Keck W. Peptide deformylase as an antibacterial drug target: Assays for detection of its inhibition in Escherichia coli cell homogenates and intact cells. Antimicrob. Agents Chemother. 2001;45:1053\u20131057. doi: 10.1128/AAC.45.4.1053-1057.2001.", "ArticleIdList": ["10.1128/AAC.45.4.1053-1057.2001", "PMC90424", "11257015"]}, {"Citation": "Hackbarth C.J., Chen D.Z., Lewis J.G., Clark K., Mangold J.B., Cramer J.A., Margolis P.S., Wang W., Koehn J., Wu C., et al. N-Alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity. Antimicrob. Agents Chemother. 2002;46:2752\u20132764. doi: 10.1128/AAC.46.9.2752-2764.2002.", "ArticleIdList": ["10.1128/AAC.46.9.2752-2764.2002", "PMC127453", "12183225"]}, {"Citation": "Bradbury B.J., Pucci M.J. Recent advances in bacterial topoisomerase inhibitors. Curr. Opin. Pharmacol. 2008;8:574\u2013581. doi: 10.1016/j.coph.2008.04.009.", "ArticleIdList": ["10.1016/j.coph.2008.04.009", "18555745"]}, {"Citation": "Pommier Y., Leo E., Zhang H., Marchand C. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem. Biol. 2010;17:421\u2013433. doi: 10.1016/j.chembiol.2010.04.012.", "ArticleIdList": ["10.1016/j.chembiol.2010.04.012", "PMC7316379", "20534341"]}, {"Citation": "Carlson E.E., May J.F., Kiessling L.L. Chemical probes of UDP-galactopyranose mutase. Chem. Biol. 2006;13:825\u2013837. doi: 10.1016/j.chembiol.2006.06.007.", "ArticleIdList": ["10.1016/j.chembiol.2006.06.007", "16931332"]}, {"Citation": "Madhurantakam C., Rajakumara E., Mazumdar P.A., Saha B., Mitra D., Wiker G.H., Sankaranarayanan R., Das A.K. Crystal structure of low-molecular-weight protein tyrosine phosphatase from Mycobacterium tuberculosis at 1.9-\u00c5 resolution. J. Bacteriol. 2005;187:2175\u20132181. doi: 10.1128/JB.187.6.2175-2181.2005.", "ArticleIdList": ["10.1128/JB.187.6.2175-2181.2005", "PMC1064030", "15743966"]}, {"Citation": "Grundner C., Perrin D., van Huijsduijnen R.H., Swinnen D., Gonzalez J., Gee C.L., Wells T.N., Alber T. Structural basis for selective inhibition of Mycobacterium tuberculosis protein tyrosine phosphatase PtpB. Structure. 2007;15:499\u2013509. doi: 10.1016/j.str.2007.03.003.", "ArticleIdList": ["10.1016/j.str.2007.03.003", "PMC2775457", "17437721"]}, {"Citation": "Seward H.E., Roujeinikova A., McLean K.J., Munro A.W., Leys D. Crystal structure of the Mycobacterium tuberculosis P450 CYP-121-fluconazole complex reveals new azol drug-P450 binding mode. J. Biol. Chem. 2006;281:39437\u201339443. doi: 10.1074/jbc.M607665200.", "ArticleIdList": ["10.1074/jbc.M607665200", "17028183"]}, {"Citation": "Belin P., le Du M.H., Fielding A., Lequin O., Jacquet M., Charbonnier J.B., Lecoq A., Thal R., Cour\u00e7on M., Masson C., et al. Identification and structural basis of the reaction catalyzed by CYP121, an essential cytochrome P450 in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA. 2009;106:7426\u20137431. doi: 10.1073/pnas.0812191106.", "ArticleIdList": ["10.1073/pnas.0812191106", "PMC2678619", "19416919"]}, {"Citation": "Kavanagh M.E., Coyne A.G., McLean K.J., James G.G., Levy C.W., Marino L.B., de Carvalho L.P., Chan D.S., Hudson S.A., Surade S., et al. Fragment-based approaches to the development of Mycobacterium tuberculosis CYP121 inhibitors. J. Med. Chem. 2016;59:3272\u20133302. doi: 10.1021/acs.jmedchem.6b00007.", "ArticleIdList": ["10.1021/acs.jmedchem.6b00007", "PMC4835159", "27002486"]}, {"Citation": "Mills S.D., Eakin A.E., Buurman E.T., Newman J.V., Gao N., Huynh H., Johnson K.D., Lahiri S., Shapiro A.B., Walkup G.K., et al. Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivo. Antimicrob. Agents Chemother. 2011;55:1088\u20131096. doi: 10.1128/AAC.01181-10.", "ArticleIdList": ["10.1128/AAC.01181-10", "PMC3067096", "21189350"]}, {"Citation": "Stokes S.S., Huynh H., Gowravaram M., Albert R., Cavero-Tomas M., Chen B., Harang J., Loch J.T., Lu M., Mullen G.B., et al. Discovery of bacterial NAD+-dependent DNA ligase inhibitors: Optimization of antibacterial activity. Bioorg. Med. Chem. 2011;21:4556\u20134560. doi: 10.1016/j.bmcl.2011.05.128.", "ArticleIdList": ["10.1016/j.bmcl.2011.05.128", "21719282"]}, {"Citation": "Nandakumar J., Nair P.A., Shuman S. Last stop on the road to repair: Structure of E. coli DNA ligase bound to nicked DNA-adenylate. Mol. Cell. 2007;26:257\u2013271. doi: 10.1016/j.molcel.2007.02.026.", "ArticleIdList": ["10.1016/j.molcel.2007.02.026", "17466627"]}, {"Citation": "Park J.K., Kim K.H., Moon J.H., Kim E.E. Characterization of peptide deformylase 2 from B. cereus. J. Biochem. Mol. Biol. 2007;6:1050\u20131057. doi: 10.5483/BMBRep.2007.40.6.1050.", "ArticleIdList": ["10.5483/BMBRep.2007.40.6.1050", "18047803"]}, {"Citation": "Clements J.M., Beckett R.P., Brown A., Catlin G., Lobell M., Palan S., Thomas W., Whittaker M., Wood S., Salama S., et al. Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor. Antimicrob. Agents Chemother. 2001;45:563\u2013570. doi: 10.1128/AAC.45.2.563-570.2001.", "ArticleIdList": ["10.1128/AAC.45.2.563-570.2001", "PMC90327", "11158755"]}, {"Citation": "Guilloteau J.P., Mathieu M., Giglione C., Blanc V., Dupuy A., Chevrier M., Gil P., Famechon A., Meinnel T., Mikol V. The crystal structures of four peptide deformylases bound to the antibiotic actinonin reveal two distinct types: A platform for the structure-based design of antibacterial agents. J. Mol. Biol. 2002;320:951\u2013962. doi: 10.1016/S0022-2836(02)00549-1.", "ArticleIdList": ["10.1016/S0022-2836(02)00549-1", "12126617"]}, {"Citation": "Smith K.J., Petit C.M., Aubart K., Smyth M., McManus E., Jones J., Fosberry A., Lewis C., Lonetto M., Christensen S.B. Structural variation and inhibitor binding in polypeptide deformylase from four different bacterial species. Protein Sci. 2003;12:349\u2013360. doi: 10.1110/ps.0229303.", "ArticleIdList": ["10.1110/ps.0229303", "PMC2312423", "12538898"]}, {"Citation": "McElroy C.A., Amero C.D., Byerly D.W., Foster M.P. Solution structure of peptide deformylase complexed with actinonin. 2009. to be published."}, {"Citation": "Cheng R.K., Crawley L., Wood M., Barker J., Felicetti B., Whittaker M. The structure of E. coli peptide deformylase (PDF) in complex with peptidomimetic ligand BB2827. 2009. to be published."}, {"Citation": "Pichota A., Duraiswamy J., Yin Z., Keller T.H., Alam J., Liung S., Lee G., Ding M., Wang G., Chan W.L., et al. Peptide deformylase inhibitors of Mycobacterium tuberculosis: Synthesis, structural investigations, and biological results. Bioorg. Med. Chem. Lett. 2008;18:6568\u20136572. doi: 10.1016/j.bmcl.2008.10.040.", "ArticleIdList": ["10.1016/j.bmcl.2008.10.040", "19008098"]}, {"Citation": "Yoon H.J., Kim H.L., Lee S.K., Kim H.W., Kim H.W., Lee J.Y., Mikami B., Suh S.W. Crystal structure of peptide deformylase from Staphylococcus aureus in complex with actinonin, a naturally occurring antibacterial agent. Proteins. 2004;57:639\u2013642. doi: 10.1002/prot.20231.", "ArticleIdList": ["10.1002/prot.20231", "15382235"]}, {"Citation": "Molteni V., He X., Nabakka J., Yang K., Kreusch A., Gordon P., Bursulaya B., Warner I., Shin T., Biorac T., et al. Identification of novel potent bicyclic peptide deformylase inhibitors. Bioorg. Med. Chem. Lett. 2004;14:1477\u20131481. doi: 10.1016/j.bmcl.2004.01.014.", "ArticleIdList": ["10.1016/j.bmcl.2004.01.014", "15006385"]}, {"Citation": "Lee S.J., Lee S.J., Lee S.K., Yoon H.J., Lee H.H., Kim K.K., Lee J.B., Lee B.I., Suh S.W. Structures of Staphylococcus aureus peptide deformylase in complex with two classes of new inhibitors. Acta Crystallogr. Sect. D. 2012;68:784\u2013793. doi: 10.1107/S0907444912011912.", "ArticleIdList": ["10.1107/S0907444912011912", "22751663"]}, {"Citation": "Fieulaine S., Desmadril M., Meinnel T., Giglione C. Understanding the highly efficient catalysis of prokaryotic peptide deformylases by shedding light on the determinants specifying the low activity of the human counterpart. Acta Crystallogr. Sect. D. 2014;70:242\u2013252. doi: 10.1107/S1399004713026461.", "ArticleIdList": ["10.1107/S1399004713026461", "24531459"]}, {"Citation": "Holdgate G.A., Tunnicliffe A., Ward W.H., Weston S.A., Rosenbrock G., Barth P.T., Taylor I.W., Pauptit R.A., Timms D. The entropic penalty of ordered water accounts for weaker binding of the antibiotic novobiocin to a resistant mutant of DNA gyrase: A thermodynamic and crystallographic study. Biochemistry. 1997;36:9663\u20139673. doi: 10.1021/bi970294+.", "ArticleIdList": ["10.1021/bi970294+", "9245398"]}, {"Citation": "Bellon S., Parsons J.D., Wei Y., Hayakawa K., Swenson L.L., Charifson P.S., Lippke J.A., Aldape R., Gross C.H. Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): A single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase. Antimicrob. Agents Chemother. 2004;48:1856\u20131864. doi: 10.1128/AAC.48.5.1856-1864.2004.", "ArticleIdList": ["10.1128/AAC.48.5.1856-1864.2004", "PMC400558", "15105144"]}, {"Citation": "Agrawal A., Rou\u00e9 M., Spitzfaden C., Petrella S., Aubry A., Hann M., Bax B., Mayer C. Mycobacterium tuberculosis DNA gyrase ATPase domain structures suggest a dissociative mechanism that explains how ATP hydrolysis is coupled to domain motion. Biochem. J. 2013;456:263\u2013273. doi: 10.1042/BJ20130538.", "ArticleIdList": ["10.1042/BJ20130538", "24015710"]}, {"Citation": "Evdokimov A.G., Pokross M., Walter R., Mekel M., Cox B., Li C., Bechard R., Genbauffe F., Andrews R., Diven C., et al. Engineering the catalytic domain of human protein tyrosine phosphatase \u03b2 for structure-based drug discovery. Acta Crystallogr. Sect. D. 2006;62:1435\u20131445. doi: 10.1107/S0907444906037784.", "ArticleIdList": ["10.1107/S0907444906037784", "17139078"]}, {"Citation": "Van Straaten K.E., Kuttiyatveetil J.R., Sevrain C.M., Villaume S.A., Jim\u00e9nez-Barbero J., Linclau B., Vincent S.P., Sanders D.A. Structural basis of ligand binding to UDP-galactose mutase from Mycobacterium tuberculosis using substrate and tetrafluorinated substrate analogs. J. Am. Chem. Soc. 2015;137:1230\u20131244. doi: 10.1021/ja511204p.", "ArticleIdList": ["10.1021/ja511204p", "25562380"]}, {"Citation": "Fonvielle M., le Du M.H., Lequin O., Lecoq A., Jacquet M., Thai R., Dubois S., Grach G., Gondry M., Belin P. Substrate and reaction specificity of Mycobacterium tuberculosis cytochrome P450 CYP121. Insights from biochemical studies and crystal structures. J. Biol. Chem. 2013;288:17347\u201317359. doi: 10.1074/jbc.M112.443853.", "ArticleIdList": ["10.1074/jbc.M112.443853", "PMC3682536", "23620594"]}, {"Citation": "Hudson S.A., Surade S., Coyne A.G., McLean K.J., Leys D., Munro A.W., Abell C. Overcoming the limitations of fragment merging: Rescuing a strained merged fragment series targeting Mycobacterium tuberculosis CYP 121. ChemMedChem. 2013;8:1451\u20131456. doi: 10.1002/cmdc.201300219.", "ArticleIdList": ["10.1002/cmdc.201300219", "PMC4281926", "23788280"]}, {"Citation": "Surivet J.P., Lange R., Hubschwerlen C., Keck W., Specklin J.L., Ritz D., Bur D., Locher H., Seiler P., Strasser D.S., et al. Structure-guided design, synthesis and biological evaluation of novel DNA ligase inhibitors with in vitro and in vivo anti-staphylococcal activity. Bioorg. Med. Chem. Lett. 2012;22:6705\u20136711. doi: 10.1016/j.bmcl.2012.08.094.", "ArticleIdList": ["10.1016/j.bmcl.2012.08.094", "23006603"]}, {"Citation": "Srivastava S.K., Tripathi R.P., Ramachandran R. NAD+-dependent DNA ligase (Rv3014c) from Mycobacterium tuberculosis. Crystal structure of the adenylation domain and identification of novel inhibitors. J. Biol. Chem. 2005;280:30273\u201330281. doi: 10.1074/jbc.M503780200.", "ArticleIdList": ["10.1074/jbc.M503780200", "15901723"]}, {"Citation": "Howard S., Amin N., Benowitz A.B., Chiarparin E., Cui H., Deng X., Heightman T.D., Holmes D.J., Hopkins A., Huang J., et al. Fragment-based discovery of 6-azaindoles as inhibitors of bacterial DNA ligase. ACS Med. Chem. Lett. 2013;4:1208\u20131212. doi: 10.1021/ml4003277.", "ArticleIdList": ["10.1021/ml4003277", "PMC4027552", "24900632"]}, {"Citation": "Thomsen R., Christensen M.H. MolDock: A new technique for high-accuracy molecular docking. J. Med. Chem. 2006;49:3315\u20133321. doi: 10.1021/jm051197e.", "ArticleIdList": ["10.1021/jm051197e", "16722650"]}, {"Citation": "Halgren T.A. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF 94. J. Comput. Chem. 1996;17:490\u2013519. doi: 10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P.", "ArticleIdList": ["10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P"]}, {"Citation": "Molegro Virtual Docke. Molegro ApS; Aarhus, Denmark: 2013. version 6.0.1."}, {"Citation": "Pan Y., Huang N., Cho S., MacKerell A.D. Consideration of molecular weight during compound selection in virtual target-based database screening. J. Chem. Inf. Comput. Sci. 2003;43:267\u2013272. doi: 10.1021/ci020055f.", "ArticleIdList": ["10.1021/ci020055f", "12546562"]}, {"Citation": "Yang J.M., Shen T.W. A pharmacophore-based evolutionary approach for screening selective estrogen receptor modulators. Proteins Struct. Funct. Bioinform. 2005;59:205\u2013220. doi: 10.1002/prot.20387.", "ArticleIdList": ["10.1002/prot.20387", "15726586"]}, {"Citation": "Huang N., Nagarsekar A., Xia G., Hayashi J., MacKerell A.D. Identification of non-phosphate-containing small molecular weight inhibitors of the tyrosine kinase p56 Lck SH2 domain via in silico screening against the pY + 3 binding site. J. Med. Chem. 2004;47:3502\u20133511. doi: 10.1021/jm030470e.", "ArticleIdList": ["10.1021/jm030470e", "15214778"]}, {"Citation": "Hancock C.N., Macias A., Lee E.K., Yu S.Y., MacKerell A.D., Shapiro P. Identification of novel extracellular signal-regulated kinase docking domain inhibitors. J. Med. Chem. 2005;48:4586\u20134595. doi: 10.1021/jm0501174.", "ArticleIdList": ["10.1021/jm0501174", "15999996"]}, {"Citation": "Abad-Zapatero C., Metz J.T. Ligand efficiency indices as guideposts for drug discovery. Drug Discov. Today. 2005;10:464\u2013469. doi: 10.1016/S1359-6446(05)03386-6.", "ArticleIdList": ["10.1016/S1359-6446(05)03386-6", "15809192"]}, {"Citation": "Carta G., Knox A.J., Lloyd D.G. Unbiasing scoring functions: A new normalization and rescoring strategy. J. Chem. Inf. Model. 2007;47:1564\u20131571. doi: 10.1021/ci600471m.", "ArticleIdList": ["10.1021/ci600471m", "17552493"]}, {"Citation": "Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 2012;64:4\u201317. doi: 10.1016/j.addr.2012.09.019.", "ArticleIdList": ["10.1016/j.addr.2012.09.019", "11259830"]}, {"Citation": "Sheriha G.M., Abouamer K., Elshtaiwi B.Z. An alkaloid from Haplophyllum tuberculatum. Phytochemistry. 1985;24:884\u2013886. doi: 10.1016/S0031-9422(00)84923-7.", "ArticleIdList": ["10.1016/S0031-9422(00)84923-7"]}, {"Citation": "Gnan S.O., Sheriha G.M. Antimicrobial activity of (+)-tuberine. J. Food Prot. 1986;49:340\u2013341.", "ArticleIdList": ["30959702"]}, {"Citation": "Kuete V., Alibert-Franco S., Eyong K.O., Ngameni B., Folefoc G.N., Nguemeving J.R., Tangmouo J.G., Fotso G.W., Komguem J., Ouahouo B.M., et al. Antibacterial activity of some natural products expressing a multidrug-resistant phenotype. Int. J. Antimicrob. Agents. 2011;37:156\u2013161. doi: 10.1016/j.ijantimicag.2010.10.020.", "ArticleIdList": ["10.1016/j.ijantimicag.2010.10.020", "21163632"]}, {"Citation": "Lavoie S., Legault J., Simard F., Chiasson E., Pickette A. New antibacterial dihydrochalcone derivatives from buds of Populus balsamifera. Tetrahedron Lett. 2013;54:1631\u20131633. doi: 10.1016/j.tetlet.2012.12.012.", "ArticleIdList": ["10.1016/j.tetlet.2012.12.012"]}, {"Citation": "Mbaveng A.T., Ngameni B., Kuete V., Simo I.K., Ambassa P., Roy R., Bezabih M., Etoa F.X., Ngadjui B.T., Abegaz B.M., et al. Antimicrobial activity of the crude extracts and five flavonoids from the twigs of Dorstenia barteri (Moraceae) J. Ethnopharmacol. 2008;116:483\u2013489. doi: 10.1016/j.jep.2007.12.017.", "ArticleIdList": ["10.1016/j.jep.2007.12.017", "18280679"]}, {"Citation": "Orjala J., Wright A.D., Behrends H., Folkers G., Sticher O., R\u00fcegger H. Cytotoxic and antibacterial dihydrochalcones from Piper aduncum. J. Nat. Prod. 1994;57:18\u201326. doi: 10.1021/np50103a003.", "ArticleIdList": ["10.1021/np50103a003", "8158163"]}, {"Citation": "Inamori Y., Baba K., Tsujibo H., Taniguchi M., Nakata K., Kozawa M. Antibacterial activity of two chalcones, xanthoangelol and 4-hydroxyderricin, isolated from the root of Angelica keiskei Koidzumi. Chem. Pharm. Bull. 1991;39:1604\u20131605. doi: 10.1248/cpb.39.1604.", "ArticleIdList": ["10.1248/cpb.39.1604", "1934181"]}, {"Citation": "Sugamoto K., Matsusita Y., Matsui K., Kurogi C., Matsui T. Synthesis and antibacterial activity of chalcones bearing prenyl or geranyl groups from Angelica keiskei. Tetrahedron. 2011;67:5346\u20135359. doi: 10.1016/j.tet.2011.04.104.", "ArticleIdList": ["10.1016/j.tet.2011.04.104"]}, {"Citation": "\u0160mejkal K., Chudik S., Klou\u010dek P., Marek R., Cva\u010dka J., Urbanov\u00e1 M., Jul\u00ednex O., Koko\u0161ka L., \u0160lapetov\u00e1 T., Holubov\u00e1 P., et al. Antibacterial C-geranylflavonoids from Poulownia tomentosa fruits. J. Nat. Prod. 2008;71:706\u2013709. doi: 10.1021/np070446u.", "ArticleIdList": ["10.1021/np070446u", "18293924"]}, {"Citation": "Nanayakkara N.P., Burandt C.L., Jacob M.R. Flavonoids with activity against methicillin-resistant Staphylococcus aureus from Dalea scandens var. paucifolia. Planta Med. 2002;68:519\u2013522. doi: 10.1055/s-2002-32554.", "ArticleIdList": ["10.1055/s-2002-32554", "12094295"]}, {"Citation": "Mitscher L.A., Gollapudi S.R., Khanna I.K., Drake S.D., Hanumaiah T., Ramaswamy T., Rao K.V. Antimicrobial agents from higher plants: Activity and structural revision of flemiflavanone-D from Flemingia stricta. Phytochemistry. 1985;24:2885\u20132997. doi: 10.1016/0031-9422(85)80020-0.", "ArticleIdList": ["10.1016/0031-9422(85)80020-0"]}, {"Citation": "Sch\u00fctz B.A., Wright A.D., Rali T., Sticher O. Prenylated flavanones from leaves of Macaranga pleiostemona. Phytochemistry. 1995;40:1273\u20131277. doi: 10.1016/0031-9422(95)00508-5.", "ArticleIdList": ["10.1016/0031-9422(95)00508-5"]}, {"Citation": "Setzer W.N., Green T.J., Lawton R.O., Moriarity D.M., Bates R.B., Caldera S., Haber W.A. An antibacterial vitamin E derivative from Tovomitopsis psychotriifolia. Planta Med. 1995;61:275\u2013276. doi: 10.1055/s-2006-958072.", "ArticleIdList": ["10.1055/s-2006-958072", "7617773"]}, {"Citation": "Petersen M., Simmonds M.S. Rosmarinic acid. Phytochemistry. 2003;62:121\u2013125. doi: 10.1016/S0031-9422(02)00513-7.", "ArticleIdList": ["10.1016/S0031-9422(02)00513-7", "12482446"]}, {"Citation": "Klan\u010dnik A., Piskernik S., Jer\u0161ek B., Mo\u017eina S. Evaluation of diffusion and dilution methods to determine the antibacterial activity of plant extracts. J. Microbiol. Methods. 2010;81:121\u2013126. doi: 10.1016/j.mimet.2010.02.004.", "ArticleIdList": ["10.1016/j.mimet.2010.02.004", "20171250"]}, {"Citation": "Bais H.P., Walker T.S., Scheizer H.P., Vivanco J.M. Root specific elicitation and antimicrobial activity of rosmarinic acid in hairy root cultures of Ocimum basilicum. Plant Physiol. Biochem. 2002;40:983\u2013995. doi: 10.1016/S0981-9428(02)01460-2.", "ArticleIdList": ["10.1016/S0981-9428(02)01460-2"]}, {"Citation": "Walker T.S., Bais H.P., D\u00e9ziel E., Schwizer H.P., Rahme L.G., Fall R., Vivanco J.M. Pseudomonas aeruginosa-plant root interactions. Pathogenicity, biofilm formation, and root exudation. Plant Physiol. 2004;124:320\u2013331. doi: 10.1104/pp.103.027888.", "ArticleIdList": ["10.1104/pp.103.027888", "PMC316311", "14701912"]}, {"Citation": "Yoshizaki F., Hisamichi S., Kondo Y., Sato Y., Nozoe S. Studies on shikon. III. New furylhydroquinone derivatives, shikonofurans A, B, C, D and E, from Lithospermum erythrorhizon Sieb. et Zucc. Chem. Pharm. Bull. 1982;30:4407\u20134411. doi: 10.1248/cpb.30.4407.", "ArticleIdList": ["10.1248/cpb.30.4407"]}, {"Citation": "Puttarak P., Charoonratana T., Panichayupakaranant P. Antimicrobial activity and stability of rhinacanthins-rich Rhinacanthus nasutus extract. Phytomedicine. 2010;17:323\u2013327. doi: 10.1016/j.phymed.2009.08.014.", "ArticleIdList": ["10.1016/j.phymed.2009.08.014", "19879741"]}, {"Citation": "Petit S., Duroc Y., Larue V., Giglione C., L\u00e9on C., Soulama C., Denis A., Dardel F., Meinnel T., Artaud I. Structure-activity relationship analysis of the peptide deformylase inhibitor 5-bromo-1H-indole-3-acetohydroxamic acid. ChemMedChem. 2009;4:261\u2013275. doi: 10.1002/cmdc.200800251.", "ArticleIdList": ["10.1002/cmdc.200800251", "19053131"]}, {"Citation": "Zhu Y., Zhang P., Yu H., Li J., Wang M.W., Zhao W. Anti-Helicobacter pylori and thrombin inhibitory components from Chinese dragon\u2019s blood, Dracaena cochinchinensis. J. Nat. Prod. 2007;70:1570\u20131577. doi: 10.1021/np070260v.", "ArticleIdList": ["10.1021/np070260v", "17883259"]}, {"Citation": "Fukai T., Kaitou K., Terada S. Antimicrobial activity of 2-arylbenzofurans from Morus species against methicillin-resistant Staphylococcus aureus. Fitoterapia. 2005;76:708\u2013711. doi: 10.1016/j.fitote.2005.06.012.", "ArticleIdList": ["10.1016/j.fitote.2005.06.012", "16236463"]}, {"Citation": "Tanaka H., Hirata M., Etoh H., Sako M., Sato M., Murata J., Murata H., Darnaedi D., Fukai T. Six new constituents from the roots of Erythrina variegata. Chem. Biodivers. 2004;1:1101\u20131108. doi: 10.1002/cbdv.200490082.", "ArticleIdList": ["10.1002/cbdv.200490082", "17191901"]}, {"Citation": "Basri D.F., Xian L.W., Shukor N.I., Latip J. Bacteriostatic antimicrobial combination: Antagonistic interaction between epsilon-viniferin and vancomycin against methicillin-resistant Staphylococcus aureus. BioMed Res. Int. 2014 doi: 10.1155/2014/461756.", "ArticleIdList": ["10.1155/2014/461756", "PMC3982270", "24783205"]}, {"Citation": "Quideau S., Deffieux D., Douat-Casassus C., Pouys\u00e9gu L. Plant polyphenols: Chemical properties, biological activities, and synthesis. Angew. Chem. Int. Ed. 2011;50:586\u2013621. doi: 10.1002/anie.201000044.", "ArticleIdList": ["10.1002/anie.201000044", "21226137"]}, {"Citation": "Gupta P.K., Sahu B. Identification of natural compound inhibitors against peptide deformylase using virtual screening and molecular docking techniques. Bull. Environ. Pharmacol. Life Sci. 2015;4:70\u201380."}, {"Citation": "Gradi\u0161ar H., Pristov\u0161ek P., Plaper A., Jerala R. Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site. J. Med. Chem. 2007;50:264\u2013271. doi: 10.1021/jm060817o.", "ArticleIdList": ["10.1021/jm060817o", "17228868"]}, {"Citation": "Hossion A.M., Zamami Y., Kandahary R.K., Tsuchiya T., Ogawa W., Iwado A., Sasaki K. Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents. J. Med. Chem. 2011;54:3686\u20133703. doi: 10.1021/jm200010x.", "ArticleIdList": ["10.1021/jm200010x", "21534606"]}, {"Citation": "Plaper A., Golob M., Hafner I., Oblak M., \u0160olmajer T., Jerala R. Characterization of quercetin binding site on GNA gyrase. Biochem. Biophys. Res. Commun. 2003;306:530\u2013536. doi: 10.1016/S0006-291X(03)01006-4.", "ArticleIdList": ["10.1016/S0006-291X(03)01006-4", "12804597"]}, {"Citation": "Verotta L., Lovaglio E., Vidari G., Finzi P.V., Neri M.G., Raimondi A., Parapini S., Taramelli D., Riva A., Bombardelli E. 4-Alkyl- and 4-phenylcoumarins from Mesua ferrea as promising multidrug resistant antibacterials. Phytochemistry. 2004;65:2867\u20132879. doi: 10.1016/j.phytochem.2004.07.001.", "ArticleIdList": ["10.1016/j.phytochem.2004.07.001", "15501254"]}, {"Citation": "Chen L., Zhou B., Zhang S., Wu L., Wang Y., Franzblau S.G., Zhang Z.Y. Identification and characterization of novel inhibitors of mPTPB, an essential virulent phosphatase from Mycobacterium tuberculosis. ACS Med. Chem. Lett. 2010;1:355\u2013359. doi: 10.1021/ml1001135.", "ArticleIdList": ["10.1021/ml1001135", "PMC2992434", "21116447"]}, {"Citation": "Wu T., Zang X., He M., Pan S., Xu X. Structure-activity relationship of flavonoids on their anti-Escherichia coli activity and inhibition of DNA gyrase. J. Agric. Food Chem. 2013;61:8185\u20138190. doi: 10.1021/jf402222v.", "ArticleIdList": ["10.1021/jf402222v", "23926942"]}, {"Citation": "Borrelli S., Zandberg W.F., Mohan S., Ko M., Martinez-Gutierrez F., Partha S.K., Sanders D.A., Av-Gay Y., Pinto B.M. Antimycrobacterial activity of UDP-galactopyranose mutase inhibitors. Int. J. Antimicrob. Agents. 2010;36:364\u2013368. doi: 10.1016/j.ijantimicag.2010.06.030.", "ArticleIdList": ["10.1016/j.ijantimicag.2010.06.030", "20678902"]}, {"Citation": "Dykhuizen E.C., May J.F., Tongpenyai A., Kiessling L.L. Inhibitors of UDP-galactopyranose mutase thwart mycobacterial growth. J. Am. Chem. Soc. 2008;130:6706\u20136707. doi: 10.1021/ja8018687.", "ArticleIdList": ["10.1021/ja8018687", "18447352"]}, {"Citation": "Jayasuriya H., Clark A.M., McChesney J.D. New antimicrobial filicinic acid derivatives from Hypericum drummondii. J. Nat. Prod. 1991;54:1314\u20131320. doi: 10.1021/np50077a013.", "ArticleIdList": ["10.1021/np50077a013", "1800634"]}, {"Citation": "Rocha L., Marston A., Potterat O., Kaplan M.A., Hostettmann K. More phloroglucinols from Hypericum brasiliense. Phytochemistry. 1996;42:185\u2013188. doi: 10.1016/0031-9422(95)00848-9.", "ArticleIdList": ["10.1016/0031-9422(95)00848-9", "8534402"]}, {"Citation": "Wang T., Duncan L., Gu W., O\u2019Dowd H., Wei Y., Perola E., Parsons J., Gross C.H., Moody C.S., Arends S.J.R., et al. Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part II: 4-Amino-pyrido[2,3-d]pyrimidin-5(8H)-ones. Bioorg. Med. Chem. Lett. 2012;22:3699\u20133703. doi: 10.1016/j.bmcl.2012.04.038.", "ArticleIdList": ["10.1016/j.bmcl.2012.04.038", "22560470"]}, {"Citation": "Siridechakorn I., Phakhodee W., Ritthiwigrom T., Promgool T., Deachathai S., Cheenpracha S., Prawat U., Laphookhieo S. Antibacterial dihydrobenzopyran and xanthone derivatives from Garcinia cowa stem barks. Fitoterapia. 2012;83:1430\u20131434. doi: 10.1016/j.fitote.2012.08.006.", "ArticleIdList": ["10.1016/j.fitote.2012.08.006", "23339255"]}, {"Citation": "Sohn H.Y., Son K.H., Kwon C.S., Kwon G.S., Kang S.S. Antimicrobial and cytotoxic activity of 18 prenylated flavonoids isolated from medicinal plants: Morus alba L., Morus mongolica Schneider, Broussnetia papyrifera (L.) Vent, Sophora flavescens Ait and Echinosophora koreensis Nakai. Phytomedicine. 2004;11:666\u2013672. doi: 10.1016/j.phymed.2003.09.005.", "ArticleIdList": ["10.1016/j.phymed.2003.09.005", "15636183"]}, {"Citation": "Chan B.C., Yu H., Wong C.W., Lui S.L., Jolivalt C., Ganem-Elbaz C., Paris J.M., Morleo B., Litaudon M., Lau C.B., et al. Quick identification of kuraridin, a noncytotoxic anti-MRSA (methicillin-resistant Staphylococcus aureus) agent from Sophora flavescens using high-speed counter-current chromatography. J. Chromatogr. B. 2012;880:157\u2013162. doi: 10.1016/j.jchromb.2011.11.039.", "ArticleIdList": ["10.1016/j.jchromb.2011.11.039", "22177235"]}, {"Citation": "Oh I., Yang W.Y., Chung S.C., Kim T.Y., Oh K.B., Shin J. In vitro sortase A inhibitory and antimicrobial activity of flavonoids isolated from the roots of Sophora flavescens. Arch. Pharm. Res. 2011;34:217\u2013222. doi: 10.1007/s12272-011-0206-0.", "ArticleIdList": ["10.1007/s12272-011-0206-0", "21380804"]}, {"Citation": "Salvatore M.J., King A.B., Graham A.C., Onishi H.R., Bartizal K.F., Abruzzo G.K., Gill C.J., Ramjit H.G., Pitzenberger S.M., Witherup K.M. Antibacterial activity of lonchocarpol A. J. Nat. Prod. 1998;61:640\u2013642. doi: 10.1021/np9703961.", "ArticleIdList": ["10.1021/np9703961", "9599265"]}, {"Citation": "Valerio L.G. In silico toxicology for the pharmaceutical sciences. Toxocol. Appl. Pharmacol. 2009;241:356\u2013370. doi: 10.1016/j.taap.2009.08.022.", "ArticleIdList": ["10.1016/j.taap.2009.08.022", "19716836"]}, {"Citation": "Yuriev E., Agostino M., Ramsland P.A. Challenges and advances in computational docking: 2009 In review. J. Mol. Recognit. 2011;24:149\u2013164. doi: 10.1002/jmr.1077.", "ArticleIdList": ["10.1002/jmr.1077", "21360606"]}, {"Citation": "Yuriev E., Ramsland P.A. Latest developments in molecular docking: 2010\u20132011 In review. J. Mol. Recognit. 2013;26:215\u2013239. doi: 10.1002/jmr.2266.", "ArticleIdList": ["10.1002/jmr.2266", "23526775"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "5", "Day": "26"}, {"Year": "2016", "Month": "8", "Day": "14"}, {"Year": "2016", "Month": "8", "Day": "26"}, {"Year": "2016", "Month": "9", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "9", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "9", "Day": "15", "Hour": "6", "Minute": "1"}, {"Year": "2016", "Month": "9", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["27626453", "PMC5039526", "10.3390/antibiotics5030030", "antibiotics5030030"]}}], "PubmedBookArticle": []}